EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair

Scott Bachus, Nikolas Akkerman, Lauren Fulham, Drayson Graves, Rafe Helwer iD, Jordan Rempel, Peter Pelka iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Scott Bachus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Manitoba, 45 Chancellor's Circle, Buller Building Room 427, Winnipeg, MB R3T 2N2, Canada. Hauptthemen laut MEDLINE: Cell Cycle Proteins, DNA Repair, Promoter Regions, Genetic, RNA Polymerase II. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arginine and glutamate rich 1 (ARGLU1) is a poorly understood cellular protein with functions in RNA splicing and transcription. Computational prediction suggests that ARGLU1 contains intrinsically disordered regions and lacks any known structural or functional domains. We used adenovirus Early protein 1A (E1A) to probe for critical regulators of important cellular pathways and identified ARGLU1 as a significant player in transcription and the DNA damage response pathway. Transcriptional effects induced by ARGLU1 occur via enhancement of promoter-proximal RNA polymerase II pausing, likely by inhibiting the interaction between JMJD6 and BRD4. When overexpressed, ARGLU1 increases the growth rate of cancer cells, while its knockdown leads to growth arrest. Significantly, overexpression of ARGLU1 increased cancer cell resistance to genotoxic drugs and promoted DNA damage repair. These results identify new roles for ARGLU1 in cancer cell survival and the DNA damage repair pathway, with potential clinical implications for chemotherapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsDNA RepairPromoter Regions, GeneticRNA Polymerase IITranscription FactorsHumansBromodomain Containing ProteinsCell Line, TumorDNA DamageDNA-Binding ProteinsJumonji Domain-Containing Histone DemethylasesNuclear ProteinsTranscription, GeneticIntracellular Signaling Peptides and Proteins

Substanzen

Bromodomain Containing ProteinsCell Cycle ProteinsDNA-Binding ProteinsJumonji Domain-Containing Histone DemethylasesNuclear ProteinsRNA Polymerase IITranscription FactorsBRD4 protein, humanSUB1 protein, humanARGLU1 protein, human

Autor:innen und Institutionen

  • Department of Microbiology, University of Manitoba, 45 Chancellor's Circle, Buller Building Room 427, Winnipeg, MB R3T 2N2, Canada.
  • Department of Medical Microbiology and Infectious Diseases, University of Manitoba, 45 Chancellor's Circle, Buller Building Room 427, Winnipeg, MB R3T 2N2, Canada.

ORCID-Profile: Rafe Helwer, Peter Pelka

Förderung

  • CIHR
  • Natural Sciences and Engineering Research Council of Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Bachus, S., Akkerman, N., Fulham, L., Graves, D., Helwer, R., Rempel, J., & Pelka, P. (2024). ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae208

Vancouver

Bachus S, Akkerman N, Fulham L, Graves D, Helwer R, Rempel J, et al. ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae208

BibTeX
@article{Bachus2024,
  author = {Bachus, Scott and Akkerman, Nikolas and Fulham, Lauren and Graves, Drayson and Helwer, Rafe and Rempel, Jordan and Pelka, Peter},
  title = {ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae208}
}
Kostenlos starten →